Global Kidney Cancer Drugs Market 2015 - Size, Share, Growth & Forecast 2019
Kidney cancer also known as renal cancer affects the kidney cells. RCC is the most common form of kidney cancer in adults and Wilms' tumor in children. The exact cause of the disease is not yet known. The symptoms of renal cancer are often confused with other kidney disorders. This usually results in late stage detection of the disease, which leads to less chances of patient survival. In the majority of cases, it is diagnosed accidentally, when the patient undergoes checkups for other disorders. Kidney cancer can be triggered by a number of factors including both lifestyle-related changes and genetic changes. The surgical removal of affected cancerous cells from the kidney provides a complete cure of the disease. A number of drugs are also available, which also help in the treatment of the disease when it is diagnosed at earlier stages. The global kidney cancer drugs market to grow at a CAGR of 7.36% over the period 2014-2019. Read more details at: http://www.bigmarketresearch.com/global-kidney-cancer-drugs-2015-2019-market
★
★
★
★
★
277 views • 8 slides